OverviewSuggest Edit

Natera (formerly known as Gene Security Network) is a genetic testing company that operates a CLIA-certified laboratory. The company offers a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; a single-gene mutation screening test to identify single-gene disorder; a carrier screening to determine carrier status for various genetic diseases that could be passed on to the carrier’s children.

TypePublic
Founded2004
HQSan Carlos, CA, US
Websitenatera.com
Employee Ratings4.1
Overall CultureD

Latest Updates

Employees (est.) (Dec 2019)1,039(+7%)
Revenue (FY, 2020)$391 M(+30%)
Share Price (Mar 2021)$123.5 (+7%)
Cybersecurity ratingBMore

Key People/Management at Natera

Steve Chapman

Steve Chapman

Chief Executive Officer and Director
Mike Brophy

Mike Brophy

Chief Financial Officer
Matthew Rabinowitz

Matthew Rabinowitz

Executive Chairman, Co-Founder
Jonathan Sheena

Jonathan Sheena

Chief Technology Officer, Co-Founder
Robert Schueren

Robert Schueren

Chief Operating Officer
Olesya Anisimova

Olesya Anisimova

Senior Vice President, Financial Controller
Show more

Natera Office Locations

Natera has an office in San Carlos
San Carlos, CA, US (HQ)
201 Industrial Rd
Show all (1)

Natera Financials and Metrics

Natera Revenue

Natera's revenue was reported to be $391.01 m in FY, 2020
USD

Revenue (FY, 2020)

391.0m

Net income (FY, 2020)

(229.7m)

EBIT (FY, 2020)

(216.3m)

Market capitalization (1-Mar-2021)

10.5b

Closing stock price (1-Mar-2021)

123.5

Cash (31-Dec-2020)

48.7m

EV

10.7b
Natera's current market capitalization is $10.5 b.
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

217.1m210.9m257.7m302.3m391.0m

Revenue growth, %

14%(3%)22%

Cost of goods sold

135.6m139.6m166.1m

Gross profit

81.5m71.3m91.6m
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

46.9m53.6m56.7m62.3m63.1m65.3m66.8m74.4m77.9m94.0m86.5m98.1m

Cost of goods sold

33.7m34.6m34.6m39.1m39.2m39.5m43.3m43.8m43.9m41.5m42.7m

Gross profit

13.2m19.1m22.0m23.3m23.9m25.8m23.5m30.5m34.0m52.5m43.7m

Gross profit Margin, %

28%36%39%37%38%40%35%41%44%56%51%
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

15.3m12.6m46.4m61.9m48.7m

Accounts Receivable

13.4m8.3m62.2m53.4m78.6m

Prepaid Expenses

7.1m8.6m6.2m16.4m26.6m

Inventories

6.4m9.0m13.6m12.4m20.0m
Quarterly
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(95.8m)(136.3m)(128.2m)(124.8m)(229.7m)

Depreciation and Amortization

6.2m7.1m7.5m7.7m8.6m

Inventories

(2.1m)(3.1m)(4.9m)917.0k(7.5m)

Accounts Payable

1.3m217.0k3.8m(6.3m)(118.0k)
USDFY, 2016

Revenue/Employee

254.8k

Debt/Equity

0.5 x

Debt/Assets

0.2 x

Financial Leverage

2 x
Show all financial metrics

Natera Operating Metrics

Q1, 2016Q2, 2016Q3, 2016FY, 2016Q1, 2017Q2, 2017Q3, 2017FY, 2017Q1, 2018Q2, 2018Q3, 2018FY, 2018Q1, 2019Q2, 2019Q3, 2019

Countries Covered

61 81 81

Covered Lives

200 m200 m200 m203 m195 m198 m198 m208 m200 m205 m205 m209 m209 m209 m209 m

Laboratory Distribution Partners

70 70 70 70 70 70 70 90 90 90 90 100 100 100 100

Tests

105 k209 k318 k447 k121 k247.10 k377.50 k515.20 k164.36 k327.16 k494.33 k668.60 k200.19 k394.66 k594.88 k
Show all operating metrics

Natera Acquisitions / Subsidiaries

Company NameDateDeal Size
Natera International, Inc.

Natera Revenue Breakdown

Embed Graph

Natera revenue breakdown by business segment: 6.7% from Licensing and Other and 93.3% from Genetic Tests

Natera revenue breakdown by geographic segment: 8.1% from Europe, Middle East, India, Africa, 87.7% from United States and 4.2% from Other

Natera Cybersecurity Score

Cybersecurity ratingPremium dataset

B

83/100

SecurityScorecard logo

Natera Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

Natera Online and Social Media Presence

Embed Graph

Natera Company Culture

  • Overall Culture

    D

    56/100

  • CEO Rating

    D-

    58/100

  • Compensation

    D

    56/100

  • Diversity

    D

    56/100

Learn more on Comparably

Natera News and Updates

Natera Reports Third Quarter 2020 Financial Results

SAN CARLOS, Calif., Nov. 5, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today reported financial results for the third quarter ended September 30, 2020 and provided an update on recent business progress. Recent Accomplishments &...

Natera Receives Final Medicare Coverage for its Signatera™ MRD Test in Stage II-III Colorectal Cancer

SAN CARLOS, Calif., Sept. 3, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the CMS Molecular Diagnostics Program (MOLDX) has finalized a local coverage determination (LCD) to provide Medicare benefits for...

Natera to Offer $250 Million Convertible Senior Notes Due 2027

SAN CARLOS, Calif., April 13, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA) today announced that it proposes to offer $250 million aggregate principal amount of convertible senior notes due 2027 (the "notes"), subject to market conditions and other factors. The notes are to be offered...

Natera Announces Preliminary First Quarter 2020 Financial Results

SAN CARLOS, Calif., April 13, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced preliminary operational and financial results for the quarter ended March 31, 2020. Natera generated total revenues of approximately $89...

Natera to Showcase Leadership in Cell-Free DNA at CEoT Conference

SAN CARLOS, Calif., March 4, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will be participating in the Cutting Edge of Transplantation (CEoT) conference taking place March 5-7, 2020 in Phoenix, Arizona. On...

Natera to Participate in Upcoming Investor Conferences

SAN CARLOS, Calif., March 3, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will webcast live presentations at the Cowen and Company 40th Annual Health Care Conference in Boston on Wednesday, March 4, 2020 at...
Show more

Natera Blogs

Why ACOG Now Supports Non-invasive Prenatal Screening (NIPS or NIPT) for All Pregnancies

The post Why ACOG Now Supports Non-invasive Prenatal Screening (NIPS or NIPT) for All Pregnancies appeared first on Natera.

Employee Spotlight: Eunice Vukosavljevic, CP

The post Employee Spotlight: Eunice Vukosavljevic, CP appeared first on Natera.

Top 10 advancements of 2020 in the oncology industry

The post Top 10 advancements of 2020 in the oncology industry appeared first on Natera.

New Data at the 2021 ASTS Winter Symposium to Showcase Benefit of Serial Prospera™ Testing

SAN CARLOS, Calif., Jan. 14, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA (cfDNA) testing, today announced it will present new data on the Prospera test at the American Society of Transplant Surgeons (ASTS) 21st Annual Winter Symposium, taking plac…

Natera to Present New Colorectal Cancer Data at the 2021 ASCO GI Symposium

Oral presentation showcases the largest early-stage CRC cohort to date, further validating the serial use of Signatera™ for early recurrence detection and MRD assessment SAN CARLOS, Calif., Jan. 12, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testi…

Natera to Webcast Live Presentation at the 39th Annual J.P. Morgan Healthcare Conference

SAN CARLOS, Calif., Jan. 5, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will webcast a live presentation at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 12, 2021 at 12:40 p.m. PT (3:40 p.m. E…
Show more

Natera Frequently Asked Questions

  • When was Natera founded?

    Natera was founded in 2004.

  • Who are Natera key executives?

    Natera's key executives are Steve Chapman, Mike Brophy and Matthew Rabinowitz.

  • How many employees does Natera have?

    Natera has 1,039 employees.

  • What is Natera revenue?

    Latest Natera annual revenue is $391 m.

  • What is Natera revenue per employee?

    Latest Natera revenue per employee is $376.3 k.

  • Who are Natera competitors?

    Competitors of Natera include Invitae, Illumina and Progenity.

  • Where is Natera headquarters?

    Natera headquarters is located at 201 Industrial Rd, San Carlos.

  • Where are Natera offices?

    Natera has an office in San Carlos.

  • How many offices does Natera have?

    Natera has 1 office.